TOPIGEN Pharmaceuticals Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Document Sample
TOPIGEN Pharmaceuticals Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Powered By Docstoc
					         TOPIGEN Pharmaceuticals Inc. - Pharmaceuticals & Healthcare - Deals and
                                   Alliances Profile
       Reference Code: GDPH141673D                                                                                                             Publication Date: JAN 2013

      Company Overview                                                                                        Key Facts
      TOPIGEN Pharmaceuticals Inc. (TOPIGEN) is a clinical-stage bio-pharmaceutical
                                                                                                              TOPIGEN Pharmaceuticals Inc., Pharmaceuticals &
      company, based in Canada. The company is engaged in the development of
                                                                                                              Healthcare, Key Facts
      innovative therapeutics for respiratory diseases. The company's discovery and
      development programs are mainly focused on achieving greater efficacy in                                 Web Address                           www.topigen.com
      respiratory diseases by inhibiting multiple inflammation-pathway targets
                                                                                                               Revenue (US$ million)                               NA
      simultaneously. As part of its business strategy, the company advances its
      compounds through phase II studies and partner for later stage development and                           Number of Employees                                        36
      commercialization. Recently, TOPIGEN initiated phase 2 clinical study of inhaled, a                      GlobalData
      multi-targeted candidate, TPI ASM8, in asthma.

      Financial Deals Landscape
        TOPIGEN Pharmaceuticals Inc., Pharmaceuticals & Healthcare,                       TOPIGEN Pharmaceuticals Inc., Pharmaceuticals &
        Deals by Type, 2007 to YTD 2013                                                   Healthcare, Deals By Year, 2007 to YTD 2013


                                                                                                                 3
                                                                                                          3


                                                                                           No. of Deals   2

                                                                                                                                           1
                                                                                                          1

                                                                                                                         0         0                 0       0        0
                                                                                                          0
                                                                                                               2007     2008      2009    2010   2011       2012   YTD
                                                                                                                                                                   2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         TOPIGEN Pharmaceuticals Inc., Pharmaceuticals &                                  TOPIGEN Pharmaceuticals Inc., Pharmaceuticals &
         Healthcare, Deals By Region, 2007 to YTD 2013                                    Healthcare, Deals By Therapy Area, 2007 to YTD 2013

                         5     4                                                                                         3
          No. of Deals




                         4                                                                                3
                                                                                           No. of Deals




                         3              2         2                                                                                        2
                         2                                 1         1                                    2
                         1                                                                                                                                   1
                         0                                                                                1
                             North    Asia-     Europe   Middle   South
                             Americ   Pacific             East     and
                               a                          and     Central                                 0
                                                         Africa   Americ                                              Ear Nose         Respiratory       Ophthalmol
                                                                    a                                                  Throat                               ogy
                                                                                                                      Disorders


         Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    Note: Deals include all announced pharmaceuticals & healthcare deals
                                                                                          from 2006 onwards, GlobalData




TOPIGEN Pharmaceuticals Inc. - Pharmaceuticals & Healthcare -                                                                                    Reference Code: GDPH141673D
Deals and Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                     Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       TOPIGEN Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ............................................... 3
       TOPIGEN Pharmaceuticals Inc., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ................................................ 5
       TOPIGEN Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ........................................... 6
       TOPIGEN Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 ................................. 7
       TOPIGEN Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 ............................................. 8
       TOPIGEN Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deal Details .................................................................................. 9
          Venture Financing........................................................................................................................................................................... 9
             Topigen Pharma Secures $25 Million In Series C Financing ...................................................................................................... 9
          Licensing Agreements .................................................................................................................................................................. 11
             TOPIGEN Pharma Enters Into Licensing Agreement With Novagali Pharma ........................................................................... 11
             Novagali Pharma Enters Into Licensing Agreement With TOPIGEN Pharma ........................................................................... 12
          Acquisition .................................................................................................................................................................................... 13
             Pharmaxis Acquires Topigen Pharma ....................................................................................................................................... 13
       TOPIGEN Pharmaceuticals Inc. - Key Competitors ......................................................................................................................... 16
       Key Employees ................................................................................................................................................................................ 17
       Locations And Subsidiaries .............................................................................................................................................................. 18
          Head Office ................................................................................................................................................................................... 18
       Appendix .......................................................................................................................................................................................... 19
   
				
DOCUMENT INFO
Description: TOPIGEN Pharmaceuticals Inc. (TOPIGEN) is a clinical-stage bio-pharmaceutical company, based in Canada. The company is engaged in the development of innovative therapeutics for respiratory diseases. The company's discovery and development programs are mainly focused on achieving greater efficacy in respiratory diseases by inhibiting multiple inflammation-pathway targets simultaneously. As part of its business strategy, the company advances its compounds through phase II studies and partner for later stage development and commercialization. Recently, TOPIGEN initiated phase 2 clinical study of inhaled, a multi-targeted candidate, TPI ASM8, in asthma. The company is operating an alliance with Novagali (SA) to develop an anti-inflammatory product to treat ocular diseases. TOPIGEN is headquartered in Quebec, Canada.
BUY THIS DOCUMENT NOW PRICE: $250 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.